AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
AAC.00905-06v1
51/4/1524    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gaudreau, C.
Right arrow Articles by Tsimiklis, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gaudreau, C.
Right arrow Articles by Tsimiklis, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, April 2007, p. 1524-1526, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.00905-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.

Comparison of Disk Diffusion and Agar Dilution Methods for Erythromycin and Ciprofloxacin Susceptibility Testing of Campylobacter jejuni subsp. jejuni{triangledown}

Christiane Gaudreau,1* Yves Girouard,2 Louise Ringuette,3 and Catherine Tsimiklis1

Hôpital Saint-Luc du Centre Hospitalier de l'Université de Montréal,1 Hôpital Sacré-Coeur, Montréal,2 Laboratoire de santé publique du Québec, Institut national de santé publique du Québec, Sainte-Anne-de-Bellevue, Québec, Canada3

Received 23 July 2006/ Returned for modification 4 August 2006/ Accepted 17 January 2007

Disk diffusion was a reliable, easy, and inexpensive method for testing the susceptibility of Campylobacter jejuni to erythromycin (215 susceptible and 45 resistant isolates) and to ciprofloxacin (154 susceptible, two intermediate, and 124 resistant isolates) using, respectively, an erythromycin disk and ciprofloxacin and nalidixic acid disks.

* Corresponding author. Mailing address: Microbiologie médicale et Infectiologie, Hôpital Saint-Luc du CHUM, 1058 rue Saint Denis, Montréal, Québec, Canada H2X 3J4. Phone: (514) 890-8305, ext. 36209. Fax: (514) 412-7412. E-mail: christiane.gaudreau.chum{at}ssss.gouv.qc.ca

{triangledown} Published ahead of print on 29 January 2007.

Antimicrobial Agents and Chemotherapy, April 2007, p. 1524-1526, Vol. 51, No. 4
0066-4804/07/$08.00+0     doi:10.1128/AAC.00905-06
Copyright © 2007, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2007 by the American Society for Microbiology. All rights reserved.